Is Weed Legal in Norway? Understanding Norway Cannabis and Marijuana Laws (2026)

No — recreational cannabis is not legal in Norway. Using, buying, holding, growing, or selling cannabis is a criminal offence, and the only lawful route to the plant is a tightly restricted medical-cannabis program that reaches very few patients. Norway has long held one of the strictest lines on drugs in Europe, and while enforcement has softened for people with serious addiction, the underlying prohibition remains firmly in place.

A high-profile attempt to decriminalize personal drug use collapsed in Parliament in 2021, and the reform that finally passed in June 2025 kept the ban intact while easing how minor offences are punished. The sections below break down what is and isn’t allowed for residents, patients, and travelers alike. For a sense of how Norway compares with its neighbors, it helps to read it alongside our guide to cannabis laws in Estonia.

Is recreational cannabis legal in Norway?

No. Recreational cannabis is illegal in Norway for possession, use, purchase, sale, and cultivation. Personal use and the possession of small amounts are handled under the Medicines Act, and the offence carries a fine or up to six months in prison.

In practice, holding up to roughly 15 grams is generally treated as a personal-use amount and resolved with a fine for first-time offenders. It is the serious category of fine, though, and it lands on a person’s criminal record, where it can affect future employment and travel. Larger quantities, supply, and trafficking are punished far more harshly, with prison terms that climb steeply as the amount involved grows.

Did Norway decriminalize cannabis?

No. Despite years of headlines suggesting otherwise, Norway never decriminalized cannabis — and the story is routinely misreported.

In December 2017, a majority in Parliament asked the government to prepare a reform that would shift responsibility for minor drug use from the justice system to the health system, loosely modeled on Portugal. That was an instruction to draft a reform, not a change to the law. The resulting decriminalization bill was voted down in the Storting on June 3, 2021, after the Labour Party broke ranks and the parliamentary majority behind it fell apart.

The courts then moved where Parliament would not. In three rulings in April 2022, Norway’s Supreme Court held that people with drug dependency should no longer be punished for using or possessing small amounts for personal use. As the Norwegian National Human Rights Institution documents, the reaction for addicted users became a waiver of sentencing or prosecution rather than a fine, and the Director of Public Prosecutions issued guidance limiting how police investigate minor drug cases — restricting house searches, phone searches, and bodily-fluid sampling for people caught with small personal-use amounts.

The long-running debate finally produced legislation in June 2025. Under the government’s prevention and treatment reform, enacted as Prop. 112 L, Parliament confirmed that drugs stay prohibited and that use and possession of small amounts remain punishable. It did introduce a model of simplified fines for minor offences by adults over 18 that are not entered on a criminal record, and it steers young people toward municipal advisory units instead of prosecution. The law stopped well short of decriminalization; the prohibition stayed in place.

Is medical cannabis legal in Norway?

Yes, but only within a narrow, doctor-controlled framework that few patients ever reach. Norway opened a regulated medical-cannabis pathway in 2016, and access is overseen by the Norwegian Medical Products Agency.

Two cannabis-based medicines are approved. Sativex is a mouth spray containing both THC and CBD, used mainly for multiple-sclerosis spasticity, and Epidyolex is a CBD solution for certain childhood epilepsies. Contrary to a common misconception, neither is synthetic — Sativex is an extract of the cannabis plant. Any doctor with the right to prescribe strong medicines can prescribe these two, and can apply for a special permit to dispense unregistered cannabis products containing up to 1% THC.

For products above 1% THC — including cannabis flower from suppliers such as the Dutch producer Bedrocan — only hospital specialists can apply for an approval exemption, and they must justify why approved medicines won’t do. There is no official list of qualifying conditions; in practice, most patients who are approved have severe pain that other treatments have failed to relieve, with multiple sclerosis, cancer, and severe epilepsy among the typical cases. Synthetic cannabinoid drugs approved abroad, such as Marinol and Cesamet, can also be sought through the same exemption route. Because many doctors remain unfamiliar with — or skeptical of — cannabis as medicine, and because the clinical evidence for some uses is still actively debated, prescriptions stay rare.

How much does medical cannabis cost, and who pays?

For most patients, the public health system does not pick up the bill. Sativex for multiple sclerosis and Epidyolex for childhood epilepsy can be covered through a hospital-prescription scheme, but the agency classifies essentially all other cannabis use as experimental treatment. That means a public hospital that starts the treatment has to fund it, patients treated outside a public hospital pay out of pocket, and the national reimbursement body provides no individual support. Combined with specialist gatekeeping and limited product availability, the result is that medical cannabis is expensive and hard to obtain.

The cost and friction push some Norwegians to seek prescriptions abroad. Patients and travelers may carry cannabis medicines into Norway under strict limits: up to one week’s supply on a foreign prescription alone, or up to 30 days’ supply with a confirming certificate from a Norwegian doctor. Neighboring Denmark’s more developed medical-cannabis scheme is one route patients have used, as our guide to cannabis laws in Denmark explains — though anything brought across the border must have been obtained legally and be properly documented.

Is CBD legal in Norway?

CBD is far more restricted in Norway than in most of Europe. Because Norway is not in the European Union, it does not follow the bloc’s hemp-CBD rules. The Norwegian Medical Products Agency classifies CBD made from cannabis extracts as a narcotic regardless of its THC content, because the underlying extracts are controlled under both Norwegian law and the UN drug conventions.

In practice, that means most CBD products require a doctor’s prescription and agency approval, the same as other cannabis medicines. Pure CBD isolate with zero THC sits in a gray area and is sometimes tolerated as a cosmetic or wellness item, but full-spectrum products are not freely sold, and customs can seize anything with detectable THC even when it was bought legally elsewhere. Mailing CBD to yourself in Norway is not permitted.

Is hemp legal in Norway?

Norway has no commercial industrial-hemp sector. The country banned hemp cultivation back in the 1960s and never reinstated it, even as the EU and many other nations built out legal hemp industries. Growing cannabis of any kind, including low-THC hemp, requires prior approval from the Norwegian Medical Products Agency, which is generally granted only for medical or scientific purposes. Importing hemp for industrial use is likewise lawful only with agency approval.

Can you grow cannabis at home in Norway?

No. Home cultivation is illegal, and growing without an official permit is treated as a drug offence rather than a gardening hobby. Penalties scale with the size of the grow and can include prison time. The only lawful cultivation is the tightly licensed kind that regulators approve for medical or research purposes.

Will Norway legalize recreational cannabis?

Not in the near term. The 2025 reform deliberately stopped short of decriminalization, let alone legalization, and the current government has ruled out lifting the ban on personal possession. The political center of gravity stays cautious, even as public attitudes shift and the courts grow more lenient toward dependent users.

Reform pressure is real, all the same. Advocacy groups such as Normal Norge and the Alliance for Rights-Oriented Drug Policies keep up the campaign, and full legalization is backed by the Young Liberals of Norway, the youth wing of the Venstre party, along with the Greens. Whether that momentum eventually overtakes Norway’s long prohibitionist tradition is, for now, an open question — and one worth following alongside the wider global legalization picture.